Global Genomic Testing in Cancer Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10243516

Publication Date:

October 24, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Manufacturing (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

According to this study, the global Genomic Testing in Cancer market size will reach US$ million by 2030.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomic Testing in Cancer market by product type, application, key players and key regions and countries.
Segmentation by product type:
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Segmentation by Application:
General Hospitals
Specialty Clinics
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genomic Testing in Cancer Market Size 2024-2030
2.1.2 Genomic Testing in Cancer Market Size CAGR by Region
2.2 Genomic Testing in Cancer Segment by Type
2.2.1 Breast Cancer
2.2.2 Lung Cancer
2.2.3 Blood Cancer
2.2.4 Liver Cancer
2.2.5 Stomach Cancer
2.2.6 Others
2.3 Genomic Testing in Cancer Market Size by Type
2.3.1 Global Genomic Testing in Cancer Market Size Market Share by Type (2024-2030)
2.3.2 Global Genomic Testing in Cancer Market Size Growth Rate by Type (2024-2030)
2.4 Genomic Testing in Cancer Segment by Application
2.4.1 General Hospitals
2.4.2 Specialty Clinics
2.5 Genomic Testing in Cancer Market Size by Application
2.5.1 Global Genomic Testing in Cancer Market Size Market Share by Application (2024-2030)
2.5.2 Global Genomic Testing in Cancer Market Size Growth Rate by Application (2024-2030)
3 Genomic Testing in Cancer Key Players
3.1 Date of Key Players Enter into Genomic Testing in Cancer
3.2 Key Players Genomic Testing in Cancer Product Offered
3.3 Key Players Genomic Testing in Cancer Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Genomic Testing in Cancer Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Genomic Testing in Cancer by Regions
4.1 Genomic Testing in Cancer Market Size by Regions (2024-2030)
4.2 United States Genomic Testing in Cancer Market Size Growth (2024-2030)
4.3 China Genomic Testing in Cancer Market Size Growth (2024-2030)
4.4 Europe Genomic Testing in Cancer Market Size Growth (2024-2030)
4.5 Rest of World Genomic Testing in Cancer Market Size Growth (2024-2030)
5 United States
5.1 United States Genomic Testing in Cancer Market Size by Type (2024-2030)
5.2 United States Genomic Testing in Cancer Market Size by Application (2024-2030)
6 Europe
6.1 Europe Genomic Testing in Cancer Market Size by Type (2024-2030)
6.2 Europe Genomic Testing in Cancer Market Size by Application (2024-2030)
7 China
7.1 China Genomic Testing in Cancer Market Size by Type (2024-2030)
7.2 China Genomic Testing in Cancer Market Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Genomic Testing in Cancer Market Size by Type (2024-2030)
8.2 Rest of World Genomic Testing in Cancer Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Genomic Testing in Cancer
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 鈥︹€�
11 Key Players Analysis
11.1 23andMe
11.1.1 23andMe Company Details
11.1.2 23andMe Genomic Testing in Cancer Product Offered
11.1.3 23andMe Genomic Testing in Cancer Market Size (2024 VS 2030)
11.1.4 23andMe Main Business Overview
11.1.5 23andMe News
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Genomic Testing in Cancer Product Offered
11.2.3 Agilent Technologies Genomic Testing in Cancer Market Size (2024 VS 2030)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies News
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Genomic Testing in Cancer Product Offered
11.3.3 Bio-Rad Laboratories Genomic Testing in Cancer Market Size (2024 VS 2030)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories News
11.4 Centogene
11.4.1 Centogene Company Details
11.4.2 Centogene Genomic Testing in Cancer Product Offered
11.4.3 Centogene Genomic Testing in Cancer Market Size (2024 VS 2030)
11.4.4 Centogene Main Business Overview
11.4.5 Centogene News
11.5 Color Genomics
11.5.1 Color Genomics Company Details
11.5.2 Color Genomics Genomic Testing in Cancer Product Offered
11.5.3 Color Genomics Genomic Testing in Cancer Market Size (2024 VS 2030)
11.5.4 Color Genomics Main Business Overview
11.5.5 Color Genomics News
11.6 Gene By Gene
11.6.1 Gene By Gene Company Details
11.6.2 Gene By Gene Genomic Testing in Cancer Product Offered
11.6.3 Gene By Gene Genomic Testing in Cancer Market Size (2024 VS 2030)
11.6.4 Gene By Gene Main Business Overview
11.6.5 Gene By Gene News
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Genomic Testing in Cancer Product Offered
11.7.3 Illumina Genomic Testing in Cancer Market Size (2024 VS 2030)
11.7.4 Illumina Main Business Overview
11.7.5 Illumina News
11.8 LabCorp
11.8.1 LabCorp Company Details
11.8.2 LabCorp Genomic Testing in Cancer Product Offered
11.8.3 LabCorp Genomic Testing in Cancer Market Size (2024 VS 2030)
11.8.4 LabCorp Main Business Overview
11.8.5 LabCorp News
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Genomic Testing in Cancer Product Offered
11.9.3 Myriad Genetics Genomic Testing in Cancer Market Size (2024 VS 2030)
11.9.4 Myriad Genetics Main Business Overview
11.9.5 Myriad Genetics News
11.10 Positive Bioscience
11.10.1 Positive Bioscience Company Details
11.10.2 Positive Bioscience Genomic Testing in Cancer Product Offered
11.10.3 Positive Bioscience Genomic Testing in Cancer Market Size (2024 VS 2030)
11.10.4 Positive Bioscience Main Business Overview
11.10.5 Positive Bioscience News
11.11 Quest Diagnostics
11.12 Thermo Fisher Scientific
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂